Search Results - "Schindeler, A."

Refine Results
  1. 1

    Cell-scaffold interactions in the bone tissue engineering triad by Murphy, Ciara M, O'Brien, Fergal J, Little, David G, Schindeler, Aaron

    Published in European cells & materials (20-09-2013)
    “…Bone tissue engineering has emerged as one of the leading fields in tissue engineering and regenerative medicine. The success of bone tissue engineering relies…”
    Get full text
    Journal Article
  2. 2

    Diagnosis of Recurrent Fracture in a Pediatric Cohort by Fiscaletti, M., Coorey, C. P., Biggin, A., Briody, J., Little, D. G., Schindeler, A., Munns, C. F.

    Published in Calcified tissue international (01-11-2018)
    “…Significant fracture history in children is defined as having at least one vertebral fracture, at least 2 fractures by age 10, or at least 3 fractures by age…”
    Get full text
    Journal Article
  3. 3

    Rescue of High Glucose Impairment of Cultured Human Osteoblasts Using Cinacalcet and Parathyroid Hormone by Shahen, V. A., Schindeler, A., Rybchyn, M. S., Girgis, C. M., Mulholland, B., Mason, R. S., Levinger, I., Brennan-Speranza, T. C.

    Published in Calcified tissue international (01-04-2023)
    “…Patients with type 2 diabetes mellitus (T2DM) experience a higher risk of fractures despite paradoxically exhibiting normal to high bone mineral density (BMD)…”
    Get full text
    Journal Article
  4. 4

    Mechanical Load Increases in Bone Formation via a Sclerostin‐Independent Pathway by Morse, Alyson, McDonald, Michelle Maree, Kelly, Natalie H, Melville, Katherine M, Schindeler, Aaron, Kramer, Ina, Kneissel, Michaela, van der Meulen, Marjolein CH, Little, David Graham

    Published in Journal of bone and mineral research (01-11-2014)
    “…ABSTRACT Sclerostin, encoded by the Sost gene, is an important negative regulator of bone formation that has been proposed to have a key role in regulating the…”
    Get full text
    Journal Article
  5. 5

    Induction of periosteal bone formation by intraosseous BMP-2 injection in a mouse model of osteogenesis imperfecta by Cheng, T. L., Cantrill, L. C., Schindeler, A., Little, D. G.

    Published in Journal of children's orthopaedics (01-10-2019)
    “…Abstract Purpose Surgical interventions are routinely performed on children with osteogenesis imperfecta (OI) to stabilize long bones, often post fracture. We…”
    Get full text
    Journal Article
  6. 6

    Targeting adeno-associated viral vectors to fractures and the skeleton by Lee, L, Peacock, L, Lisowski, L, Little, D, Munns, C, Schindeler, A

    Published in Cytotherapy (Oxford, England) (01-05-2019)
    “…Background & AimGene therapy in the context of the bone remains an underdeveloped field, and most approaches have focused on local delivery of therapeutic…”
    Get full text
    Journal Article
  7. 7

    Modulation of endochondral ossification by MEK inhibitors PD0325901 and AZD6244 (Selumetinib) by El-Hoss, J, Kolind, M, Jackson, M.T, Deo, N, Mikulec, K, McDonald, M.M, Little, C.B, Little, D.G, Schindeler, A

    Published in Bone (New York, N.Y.) (01-02-2014)
    “…Abstract MEK inhibitors (MEKi) PD0325901 and AZD6244 (Selumetinib) are drugs currently under clinical investigation for cancer treatment, however the Ras–MAPK…”
    Get full text
    Journal Article
  8. 8
  9. 9

    A sugar-based phase-transitioning delivery system for bone tissue engineering by Cheng, T L, Valtchev, P, Murphy, C M, Cantrill, L C, Dehghani, F, Little, D G, Schindeler, A

    Published in European cells & materials (22-10-2013)
    “…Bone tissue engineering approaches commonly involve the delivery of recombinant human bone morphogenetic proteins (rhBMPs). However, there are limitations…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Modulation of anabolic and catabolic responses via a porous polymer scaffold manufactured using thermally induced phase separation by Yu, Nicole Y C, Schindeler, Aaron, Peacock, Lauren, Mikulec, Kathy, Fitzpatrick, Jane, Ruys, Andrew J, Cooper-White, Justin J, Little, David G

    Published in European cells & materials (27-02-2013)
    “…We describe two studies encompassing the iterative refinement of a polymer-based rhBMP-2 delivery system for bone tissue engineering. Firstly, we compared the…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Spatial control of bone formation using a porous polymer scaffold co-delivering anabolic rhBMP-2 and anti-resorptive agents by Yu, N Y C, Gdalevitch, M, Murphy, C M, Mikulec, K, Peacock, L, Fitzpatrick, J, Cantrill, L C, Ruys, A J, Cooper-White, J J, Little, D G, Schindeler, A

    Published in European cells & materials (31-01-2014)
    “…Current clinical delivery of recombinant human bone morphogenetic proteins (rhBMPs) utilises freeze-dried collagen. Despite effective new bone generation,…”
    Get full text
    Journal Article
  16. 16

    In vivo local co-delivery of recombinant human bone morphogenetic protein-7 and pamidronate via poly-D, L-lactic acid by Yu, Nicole Y C, Schindeler, Aaron, Peacock, Lauren, Mikulec, Kathy, Baldock, Paul A, Ruys, Andrew J, Little, David G

    Published in European cells & materials (22-12-2010)
    “…The effects of bone anabolic agents such as bone morphogenetic proteins (BMPs) have the potential to be augmented by co-treatment with an anti-catabolic such…”
    Get full text
    Journal Article
  17. 17

    The anabolic and catabolic responses in bone repair by LITTLE, D. G, RAMACHANDRAN, M, SCHINDELER, A

    “…The literature on fracture repair has been reviewed. The traditional concepts of delayed and nonunion have been examined in terms of the phased and balanced…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20